Developing cell therapy for Parkinson's disease
IND-enabling studies for cell therapy in Parkinson's disease
This study is exploring a new way to use special cells to help treat Parkinson's disease by improving how these cells are delivered to the brain, with the hope of making life better for patients living with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Neoneuron, LLC NIH-funded |
| Lab location | 1 site (San Antonio, UNITED STATES) |
| Project ID | NIH-10932228 on NIH RePORTER |
What this research studies
This research focuses on creating a new cell therapy approach for treating Parkinson's disease, which currently has no cure. The study aims to improve the delivery and effectiveness of cell transplantation using induced pluripotent stem cells (iPSCs) to restore dopamine-producing neurons in the brain. By refining the cellular products and clinical protocols, the research seeks to enhance patient outcomes and address the limitations of existing treatments. Patients may benefit from innovative therapies that could significantly improve their quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with Parkinson's disease and experiencing significant symptoms.
Not a fit: Patients with Parkinson's disease who are not eligible for cell therapy or those with advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment option that restores function and alleviates symptoms for Parkinson's disease patients.
How similar studies have performed: Previous studies have shown promise in using cell transplantation for Parkinson's disease, but this approach with iPSCs is relatively novel and aims to address existing challenges.
Where this research is happening
San Antonio, UNITED STATES
- Neoneuron, LLC — San Antonio, United States (Active)
Researchers
- Principal investigator: Daadi, Marcel — Neoneuron, LLC
- Study coordinator: Daadi, Marcel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.